Despite the risk of errors and inconsistencies in manual documentation, most radiology departments lack the tools to automate documentation of contrast media administered intravenously. Like all pharmaceuticals, iodinated contrast media administered intravenously is associated with risks and the potential for adverse side effects. Ready access to reliable documentation can aid in managing the infrequent but potentially serious events that can occur.
The importance of reliable documentation
Additional considerations underscore the importance of ensuring accurate, consistent documentation of contrast media administered intravenously:
- Intravenous radiocontrast agents have a heightened risk of causing significant patient harm when used in error, according to the Institute for Safe Medication Practices.¹
- The U.S. Pharmacopeia reports that contrast agents represent nine of the top-25 most frequently reported medication errors.²
Using documentation as a quality-management tool
When incomplete injections or other quality concerns arise, accurate and consistently recorded injection-record histories can provide insight into root cause. Evaluating the injection protocol programmed and the injection protocol delivered provides additional insight, especially with access to reliable documentation details, such as:
- The administering technologist
- Catheter gauge inserted
- Flow rates selected and pressures delivered
On an ongoing basis, healthcare professionals can also monitor and drive measured return on contrast-administration and study-outcome metrics, including:
- Protocol adherence
- Atypical events (pressure limits, injections terminated by users, disarms, etc.
- Unnecessary rescans and compliance non-conformities
¹http://www.ismp.org/tools/highalertmedications.pdf (accessed 04/19/11)
²Santell JP, Hicks RW, Cousins DD. MEDMARX Data Report: A Chartbook of 2000-2004 Findings from Intensive Care Units and Radiological Services. Rockville, Md: 2005.